RUSH COUNTY — A 21-year-old Greensburg woman was fatally struck by a car Friday while she was lying in a roadway after she wandered from the scene of a rollover crash.
Before being struck, Colleen Bray was driving a Chevrolet pickup south on Ind. 3 when her car left the road and rolled over, according to a news release from Indiana State Police.
Bray then got out of the pickup, walked north on Ind. 3, and at some point became incapacitated and lied in a northbound lane near the Rush/Decatur County line.
MORE | Two 13-year-olds arrested in killing of 77-year-old woman, burglary in Indianapolis
Then, at about 7 a.m., the driver of a Chevrolet Traverse traveling north struck Bray as she lied in the roadway.
Bray was pronounced dead at the scene.
The Traverse driver was transported to Rush County Hospital, where she underwent a chemical test. Police do not believe drugs or alcohol were contributing factors in the crash.
MORE | Woman fatally shot outside shopping center on Indy's northwest side
ISP said that driver is cooperating with their investigation.
Investigators are searching for a maroon vehicle with front-end damage that may have been involved in the crash, ISP said late Friday.
Anyone with more information is urged to contact ISP at 765-778-2121 or the Rush County Sheriff's Department at 765-932-2931.
An investigation is ongoing and will be reviewed by the Rush County Prosecutor's Office once complete, police said.
-
Indiana State Fairgrounds to host 2nd Indianapolis Pizza Festival
Many of Indiana’s top pizzerias will come together on October 17 at the Indiana State Fairgrounds for the Indiana State Fair’s second Indianapolis Pizza Festival.
Court spares Trump from paying $83 million defamation award to E. Jean Carroll
The 2nd U.S. Circuit Court of Appeals agreed to a request by one of Trump's lawyers that it let the president delay the payment to E. Jean Carroll.
IndyCar drivers share excitement at open practice
As the big day gets closer, many IndyCar drivers gave their thoughts on the first day of open practice.
AI and GLP-1 drugs: Eli Lilly & Co.’s CEO talks of focus beyond 150 years
Eli Lilly & Co. CEO David Ricks on Tuesday said the company is investing heavily in artificial intelligence as well as follow-ons to its early weight-loss drugs.